The Blood Cancer Diagnostics Landscape Is Slated To Reach A Valuation Of US$ 28.57 Billion by 2032
In FY 2021, the blood cancer diagnostics market reached a valuation of US$ 15.05 Billion, and is likely to register a Y-o-Y growth rate of 5.6% in 2022, [read full press release…]